NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
4-amino-1,2-oxazolidin-3-one
|
|
|
IUPAC Traditional name
|
DL-cycloserine
|
(+-)-4-amino-3-isoxazolidinone
|
|
|
Brand Name
|
Closerin
|
Closina
|
Cyclomycin
|
Cyclorin
|
Cycloserin
|
Farmiserina
|
Farmiserine
|
Micoserina
|
Miroserina
|
Miroseryn
|
Novoserin
|
Orientomycin
|
Oxamicina
|
Oxamycin
|
Oxymycin
|
Seromycin
|
Tebemicina
|
Tisomycin
|
Wasserina
|
|
|
Synonyms
|
4-Amino-3-isoxazolidone
|
DL-Cycloserine
|
4-Amino-3-isoxazolidinone
|
(R)-(+)-4-Amino-3-isoxazolidinone
|
D-Cycloserine
|
D-Cycloserine
|
(+/-)-3-Oxoisooxazolidin-4-amine
|
rac Cycloserine
|
4-amino-1,2-oxazolidin-3-one
|
4-Aminoisoxazolidin-3-one
|
alpha-Cycloserine
|
Cicloserina
|
D-CS
|
D-Cycloserine
|
D-Cycloserine synth. BP 88
|
D-Cycloserine, synthetic
|
D-Oxamicina
|
D-Oxamycin
|
DL-Cycloserine
|
L-Cycloserine
|
Cycloserine
|
4-氨基-3-异噁唑烷酮
|
DL-环丝氨酸
|
D-环丝氨酸
|
|
|
CAS Number
|
|
EC Number
|
|
MDL Number
|
MFCD00005353
|
MFCD00064323
|
|
|
Beilstein Number
|
|
Merck Index
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
ALOGPS 2.1
Acid pKa
|
4.210087
|
H Acceptors
|
3
|
H Donor
|
2
|
LogD (pH = 5.5)
|
-2.4357781
|
LogD (pH = 7.4)
|
-2.4206417
|
Log P
|
-2.4213324
|
Molar Refractivity
|
21.8488 cm3
|
Polarizability
|
9.062646 Å3
|
Polar Surface Area
|
64.35 Å2
|
Rotatable Bonds
|
0
|
Lipinski's Rule of Five
|
true
|
Log P
|
-2.31
|
LOG S
|
0.93
|
Solubility (Water)
|
8.77e+02 g/l
|
DETAILS
DETAILS
DrugBank
Sigma Aldrich
TRC
DrugBank -
DB00260
|
Item |
Information |
Drug Groups
|
approved |
Description
|
Antibiotic substance produced by Streptomyces garyphalus. [PubChem] |
Indication |
Used in combination with up to 5 other drugs as a treatment for Mycobacterium avium complex (MAC) and is also used to treat tuberculosis (TB). |
Pharmacology |
Cycloserine, a broad-spectrum antibiotic, may be bactericidal or bacteriostatic, depending on its concentration at the site of infection and the susceptibility of the organism. Cycloserine works by blocking the formation of these peptidoglycans. By doing this the walls of the bacteria become weak and it results in the death of the bacteria |
Toxicity |
Oral LD50 in mouse is 5290 mg/kg, and in rat is over 5000 mg/kg. Symptoms of a cycloserine overdose include drowsiness, confusion, headache, dizziness, irritability, numbness and tingling, difficulty speaking, paralysis, abnormal behavior, seizures, and unconsciousness. |
Affected Organisms |
• |
Enteric bacteria and other eubacteria |
|
Absorption |
Rapidly and almost completely absorbed (70 to 90%) from the gastrointestinal tract following oral administration. |
Half Life |
Half-life in patients with normal renal function is 10 hours, and is prolonged in patients with impaired renal function. |
External Links |
|
|
Sigma Aldrich -
C7005
|
Biochem/physiol Actions Inhibitor of alanine aminotransferase and other pyridoxal-phosphate-requiring transaminases1; blocks sphingosine biosynthesis by inhibition of ketosphinganine synthetase. |
Sigma Aldrich -
862002
|
Biochem/physiol Actions Inhibitor of alanine aminotransferase and other pyridoxal-phosphate-requiring transaminases1; blocks sphingosine biosynthesis by inhibition of ketosphinganine synthetase. |
REFERENCES
REFERENCES
From Suppliers
Google Scholar
PubMed
Google Books
- • Lamb., J.W., et al.: Anal. Profiles Drug Subs., 1, 53 (1972)
- • Gentry-Weeks, C., et al.: J. Biol. Chem., 268, 7298 (1972)
- • Alexander, F., et al.: Eur. J. Biochem., 219, 953 (1972)
- • Auger, S., et al.: Biochimie, 87, 231 (1972)
- Searching...Please wait...
PATENTS
PATENTS
PubChem Patent
Google Patent